Neocortical and cerebellar developmental abnormalities in conditions of selective elimination of peroxisomes from brain or from liver

Journal of Neuroscience Research

Volumn 85, Issue 1, 2007, Pages 58-72

  Krysko, Olga ^a   Hulshagen, Leen ^a   Janssen, Anneleen ^a   Schütz, Günter ^b   Klein, Rüdiger ^c   De Bruycker, Melina ^d   Espeel, Marc ^d   Gressens, Pierre ^e   Baes, Myriam ^a  

^a DEPARTMENT OF PHARMACEUTICAL AND PHARMACOLOGICAL SCIENCES   (Belgium)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

^d GHENT UNIVERSITY   (Belgium)

^e HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Cerebellum; Development peroxisome; Liver; Mouse models; Neocortex

Indexed keywords

NESTIN; PEROXIN; PROTEIN P21; PROTEIN PEX5; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BRAIN DEVELOPMENT; BRAIN REGION; CELL DEATH; CELL MIGRATION; CEREBELLUM CORTEX; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; MOUSE; NONHUMAN; PEROXISOME; PRIORITY JOURNAL;

AGE FACTORS; ANIMALS; BLOTTING, NORTHERN; BRAIN CHEMISTRY; CELL MOVEMENT; CEREBELLUM; DEOXYADENINE NUCLEOTIDES; DISEASE MODELS, ANIMAL; EMBRYO; FEMALE; IMMUNOHISTOCHEMISTRY; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, ELECTRON, TRANSMISSION; NEOCORTEX; NEURONS; PEROXISOMES; PREGNANCY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; ZELLWEGER SYNDROME;

EID: 33846166061     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21097     Document Type: Article

References (42)

1. Baes M, Gressens P, Baumgart E, Carmeliet P, Casteels M, Fransen M, Evrard P, Fahimi D, Declercq PE, Collen D, Van Veldhoven PP, Mannaerts GP. 1997. A mouse model for Zellweger syndrome. Nat Genet 17:49-57.
2. Baes M, Dewerchin M, Janssen A, Collen D, Carmeliet P. 2002. Generation of Pex5-loxP mice allowing the conditional elimination of peroxisomes. Genesis 32:177-178.
3. Bates B, Rios M, Trumpp A, Chen C, Fan G, Bishop JM, Jaenisch R. 1999. Neurotrophin-3 is required for proper cerebellar development. Nat Neurosci 2:115-117.
4. Baumgart E, Vanhorebeek I, Grabenbauer M, Borgers M, Declercq P, Fahimi HD, Baes M. 2001. Mitochondrial alterations caused by defective peroxisomal biogenesis in a mouse model for Zellweger syndrome (PEX5 knockout mouse). Am J Pathol 159:1477-1494.
5. Behar TN, Scott CA, Greene CL, Wen X, Smith SV, Maric D, Liu Q-Y, Colton CA, Barker JL. 1999. Glutamate acting at NMDA receptors stimulates embryonic cortical neuronal migration. J Neurosci 19:4449-4461.
6. Bielas S, Higginbotham H, Koizumi H, Tanaka T, Gleeson JG. 2004. Cortical neuronal migration mutants suggest separate but intersecting pathways. Annu Rev Cell Dev Biol 20:593-618.
7. Brites P, Motley AM, Gressens P, Mooyer PAW, Ploegaert I, Everts V, Evrard P, Carmeliet P, Dewerchin M, Duran M, Waterham HR, Wanders RJA, Baes M. 2003. Impaired neuronal migration and endochondral ossification in PEX7 knockout mice: a model for rhizomelic chondrodysplasia punctata. Hum Mol Genet 12: 2255-2267.
8. Dirkx R, Vanhorebeek I, Martens K, Schad A, Grabenbauer M, Fahimi D, Declercq P, Van Veldhoven PP, Baes M. 2005. Absence of peroxisomes in hepatocytes causes mitochondrial and ER abnormalities. Hepatology 41:868-878.
9. Evrard P, Caviness VS, Prats-Vinas J, Lyon G. 1978. The mechanism of arrest of neuronal migration in the Zellweger malformation: an hypothesis based upon cytoarchitectonic analysis. Acta Neuropathol 41:109-117.
10. Faust PL. 2003. Abnormal cerebellar histogenesis in Pex2 Zellweger mice reflects multiple neuronal defects induced by peroxisome deficiency. J Comp Neurol 461:394-413.
11. Faust PL, Hatten ME. 1997. Targeted deletion of the PEX2 peroxisome assembly gene in mice provides a model for Zellweger syndrome, a human neuronal migration disorder. J Cell Biol 139:1293-1305.
12. Faust PL, Su H-M, Moser A, Moser HW. 2001. The peroxisome deficient PEX2 Zellweger mouse. J Mol Neurosci 16:289-297.
13. Faust PL, Banka D, Siriratsivawong R, Ng VG, Wikander TM. 2005. Peroxisome biogenesis disorders: the role of peroxisomes and metabolic dysfunction in developing brain. J Inherit Metab Dis 28:369-383.
14. Gould SJ, Raymond GV, Valle D. 2001. The peroxisome biogenesis disorders. In: Scriver CR, Beaudet AL, Valle D, Sly WS, editors. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill. p 3181-3217.
15. Graus-Porta D, Blaess S, Senften M, Littlewood-Evans A, Damsky C, Huang Z, Orban P, Klein R, Schittny JC, Müller U. 2003. Beta1-class integrins regulate the development of laminae and folia in the cerebral and cerebellar cortex. Neuron 31:367-379.
16. Gressens P. 2006. Pathogenesis of migration disorders. Curr Opin Neurol 19:135-140.
17. Gressens P, Baes M, Leroux P, Lombet A, Van Veldhoven P, Janssen A, Vamecq J, Marret S, Evrard P. 2000. Neuronal migration disorder in Zellweger mice is secondary to glutamate receptor dysfunction. Ann Neurol 48:336-343.
18. Hatten ME, Mason CA. 1990. Mechanisms of glial-guided neuronal migration in vitro and in vivo. Experienta 46:907-916.
19. Huyghe S, Casteels M, Janssen A, Meulders L, Mannaerts GP, Declercq PE, Van Veldhoven PP, Baes M. 2001. Prenatal and postnatal development of peroxisomal lipid-metabolizing pathways in the mouse. Biochem J 353:673-680.
20. Janssen A, Baes M, Gressens P, Mannaerts GP, Declercq P, Van Veldhoven PP. 2000. Docosahexaenoic acid deficit is not a major pathogenic factor in peroxisome-deficient mice. Lab Invest 80:31-35.
21. Janssen A, Gressens P, Grabenbauer M, Baumgart E, Schad A, Vanhorebeek I, Brouwers A, Declercq PE, Fahimi D, Evrard P, Schoonjans L, Collen D, Carmeliet P, Mannaerts G, Van Veldhoven P., Baes M. 2003. Neuronal migration depends on intact peroxisomal function in brain and in extraneuronal tissues. J Neurosci 23:9732-9741.
22. 32P-labeled substrate. Clin Chem 40:946-947.
23. Kellendonk C, Opherk C, Anlag K, Schutz G, Tronche F. 2000. Hepatocyte-specific expression of Cre recombinase. Genesis 26:151-153.
24. Komuro H, Rakic P. 1992. Selective role of N-type calcium channels in neuronal migration. Science 257:806-809.
25. Komuro H, Rakic P. 1993. Modulation of neuronal migration by NMDA receptors. Science 260:95-97.
26. S, Qiu F, Xu A, Price SM, Xiang M. 2004. Barhl1 regulates migration and survival of cerebellar granule cells by controlling expression of the neurotrophin-3 gene. J Neurosci 24:3104-3114.
27. Maxwell M, Bjorkman J, Nguyen T, Sharp P, Finnie J, Paterson C, Tonks I, Paton BC, Kay GF, Crane DI. 2003. Pex13 inactivation in the mouse disrupts peroxisome biogenesis and leads to a Zellweger syndrome phenotype. Mol Cell Biol 23:5947-5957.
28. Minichiello L, Klein R. 1996. TrkB and TrkC neurotrophin receptors cooperate in promoting survival of hippocampal and cerebellar granule neurons. Genes Dev 10:2849-2858.
29. Nagase T, Shimozawa N, Takemoto Y, Suzuki Y, Komori M, Kondo N. 2004. Peroxisomal localization in the developing mouse cerebellum: implications for neuronal abnormalities related to deficiencies in peroxisomes. Biochim Biophys Acta 1671:26-33.
30. Nystuen A, Legare ME, Shultz LD, Frankel WN. 2001. A null mutation in inositol polyphosphate 4-phosphatase type I causes selective neuronal loss in weeble mutant mice. Neuron 32:203-212.
31. Powers JM, Moser HW. 1998. Peroxisomal disorders: genotype, phenotype, major neuropathologic lesions, and pathogenesis. Brain Pathol 8:101-120.
32. Powers JM, Moser HW, Moser AB, Upshur JK, Bradford BF, Pai SG, Kohn PH, Frias J, Tiffany C. 1985. Fetal cerebrohepatorenal (Zellweger) syndrome: dysmorphic, radiologic, biochemical, and pathologic findings in four affected fetuses. Hum Pathol 16:610-620.
33. Rakic P, Cameron RS, Komuro H. 1994. Recognition, adhesion, transmembrane signaling and cell motility in guided neuronal migration. Neurobiology 4:63-69.
34. Roberts MR, Bittman K, Li WW, French R, Mitchell B, LoTurco JJ, D'Mello SR. 2000. The flathead mutation causes CNS-specific developmental abnormalities and apoptosis. J Neurosci 20:2295-2306.
35. Roels F, Espeel M, De Craemer D. 1991. Liver pathology and immunocytochemistry in congenital peroxisomal diseases: a review. J Inherit Metab Dis 14:853-875.
36. -/- mice reveals a role for neurotrophins in CNS patterning. Neuron 19:269-281.
37. Selimi F, Vogel MW, Mariani J. 2000. Bax inactivation in lurcher mutants rescues cerebellar granule cells but not Purkinje cells or inferior olivary neurons. J Neurosci 20:5339-5345.
38. Tronche F, Kellendonk C, Kretz O, Gass P, Anlag K, Orban PC, Bock R, Klein R, Schütz G. 1999. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet 23: 99-103.
39. Tronche F, Opherk C, Kellendonk C, Reichardt HM, Stangl K, Gau D, Schwake L, Hoeflich A, Schmid W, Beug H, Moriggl R, Schütz G. 2004. Glucocorticoid receptor function in hepatocytes is essential to proote post-natal body growth. Genes Dev 18:492-497.
40. Van Veldhoven PP, Just WW, Mannaerts GP. 1987. Permeability of the peroxisomal membrane to cofactors of β-oxidation. J Biol Chem 262: 4310-4318.
41. Volpe JJ, Adams RD. 1972. Cerebro-hepato-renal syndrome of Zellweger: an inherited disorder of neuronal migration. Acta Neuropathol 20:175-198.
42. Zimmerman L, Lendahl U, Cunningham M, McKay R, Parr B, Gavin B, Mann J, Vassileva G, McMahon A. 1994. Independent regulatory elements in the nestin gene direct transgene expression to neural stem cells or muscle precursors. Neuron 12:11-24.